Individuals surveyed in seven international locations extra more likely to see the AstraZeneca vaccine as unsafe than secure, YouGov finds.
Confidence within the security of AstraZeneca’s COVID vaccine has taken a giant hit in Spain, Germany, France and Italy as studies of uncommon blood clots have been linked to it and lots of international locations briefly stopped utilizing it, ballot knowledge confirmed.
Polling agency YouGov mentioned on Monday it had already present in late February that Europeans have been extra hesitant in regards to the AstraZeneca vaccine than about these from Pfizer-BioNTech and Moderna and that the clot issues had additional broken public perceptions of the AstraZeneca shot’s security.
A minimum of 13 European international locations up to now two weeks stopped administering the AstraZeneca shot, co-developed with scientists at Oxford College, after studies of a small variety of blood issues.
Many resumed its use on Friday after the European Medicines Company regulator mentioned in a preliminary security assessment on Thursday that the vaccine was secure and efficient and never linked with an increase within the total danger of blood clots.
EMA didn’t rule out a potential hyperlink, nonetheless, with uncommon instances of blood clots within the mind often called cerebral venous sinus thrombosis (CVST).
YouGov’s ballot – which coated about 8,000 folks in seven European international locations between March 12 and 18 – discovered that in France, Germany, Spain and Italy, folks have been now extra more likely to see the AstraZeneca vaccine as unsafe than as secure.
Some 55 % of Germans say it’s unsafe, whereas lower than a 3rd assume it’s secure, the ballot confirmed. In France, the place AstraZeneca’s COVID vaccine was already unpopular, 61 % of individuals polled say they now see it as unsafe.
In Italy and Spain, most individuals beforehand felt the AstraZeneca vaccine was secure – at 54 % and 59 % respectively – however these charges have fallen to 36 % and 38 % respectively, within the newest ballot.
The survey confirmed that solely in Britain, the place the AstraZeneca vaccine has been utilized in a nationwide rollout since January, have blood clot issues had little to no affect on public confidence. The vast majority of folks polled within the UK – 77 % – nonetheless say it’s secure. Their belief in it’s on a par with Pfizer’s 79 % perceived security ranking.
YouGov additionally mentioned there gave the impression to be no spillover issues throughout the seven European international locations polled for the Pfizer and Moderna COVID-19 vaccines, each of which have been seen as being as secure as in a ballot three weeks in the past.